Part D Proposal Aims to Improve Prior Authorization, Patient Access, and Equity in Coverage and Care
On December 14, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would revise regulations governing Medicare Advantage (MA or Part C), the Medicare Prescription Drug Benefit (Part D), Medicare cost plans, and Programs of All-Inclusive Care for the Elderly (PACE).
Recent News & Updates
Consumers can now purchase Exact Sciences’ liquid biopsy early detection test, Cancerguard, and get an indication of whether they might have one of 50 different cancers included in the test’s analysis.
Getting a cancer diagnosis can be overwhelming and frightening. This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.
Appendix cancer is a condition that, until recently, was so rare that most people never gave it a second thought.
Sociodemographic factors may influence cancer survivors’ ability to access pharmacologic treatment for mental health conditions, according to study results.
